Suppr超能文献

在药代动力学建模中生成和应用替身。

Generation and application of avatars in pharmacometric modelling.

机构信息

Department of Pharmacy, Uppsala University, Box 580, Uppsala, 75123, Sweden.

出版信息

J Pharmacokinet Pharmacodyn. 2023 Oct;50(5):411-423. doi: 10.1007/s10928-023-09873-9. Epub 2023 Jul 24.

Abstract

Simulations from population models have critical applications in drug discovery and development. Avatars or digital twins, defined as individual simulations matching clinical criteria of interest compared to observations from a real subject within a predefined margin of accuracy, may be a better option for simulations performed to inform future drug development stages in cases where an adequate model is not achievable. The aim of this work was to (1) investigate methods for generating avatars with pharmacometric models, and (2) explore the properties of the generated avatars to assess the impact of the different selection settings on the number of avatars per subject, their closeness to the individual observations, and the properties of the selected samples subset from the theoretical model parameters probability density function. Avatars were generated using different combinations of nature and number of clinical criteria, accuracy of agreement, and/or number of simulations for two examples models previously published (hemato-toxicity and integrated glucose-insulin model). The avatar distribution could be used to assess the appropriateness of the models assumed parameter distribution. Similarly it could be used to assess the models ability to properly describe the trajectories of the observations. Avatars can give nuanced information regarding the ability of a model to simulate data similar to the observations both at the population and at the individual level. Further potential applications for avatars may be as a diagnostic tool, an alternative to simulations with insurance to replicate key clinical features, and as an individual measure of model fit.

摘要

基于人群模型的模拟在药物发现和开发中具有重要应用。虚拟人或数字孪生体是指与临床感兴趣的标准相匹配的个体模拟,与真实受试者的观察结果相比,在预定的精度范围内具有较高的相似度,可以作为替代方案,用于模拟在无法实现充分模型的情况下,为未来的药物开发阶段提供信息。本研究的目的是:(1)探索使用药代动力学模型生成虚拟人的方法;(2)探索生成的虚拟人的特性,以评估不同选择设置对每个受试者的虚拟人数量、它们与个体观察值的接近程度以及从理论模型参数概率密度函数中选择样本子集的特性的影响。使用两种先前发表的模型(血液毒性和整合血糖-胰岛素模型),根据临床标准的性质和数量、一致性精度以及/或模拟次数的不同组合,生成虚拟人。虚拟人分布可用于评估模型假设参数分布的适宜性。同样,它也可以用于评估模型正确描述观察轨迹的能力。虚拟人可以提供关于模型模拟与观察结果相似数据的能力的详细信息,包括在人群和个体水平上。虚拟人的进一步潜在应用可能是作为诊断工具、替代保险模拟以复制关键临床特征,以及作为模型拟合的个体衡量标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27b/10460751/956b2c43234d/10928_2023_9873_Fig8_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验